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Abstract
Background: Melanomas, highly malignant tumors arise from the melanocytes which originate as multipotent
neural crest cells during neural tube genesis. The purpose of this study is to assess the pattern of neural
differentiation in relation to angiogenesis in VGP melanomas using the tumor as a three dimensional system.
Methods: Tumor-vascular complexes [TVC] are formed at the tumor-stroma interphase, by tumor cells ensheathing
angiogenic vessels to proliferate into a mantle of 5 to 6 layers [L1 to L5] forming a perivascular mantle zone [PMZ].
The pattern of neural differentiation is assessed by immunopositivity for HMB45, GFAP, NFP and synaptophysin has
been compared in: [a] the general tumor [b] tumor-vascular complexes and [c] perimantle zone [PC] on serial
frozen and paraffin sections. Statistical Analysis: ANOVA: Kruskal-Wallis One Way Analysis of Variance; All Pairwise
Multiple Comparison Procedures [Tukey Test].
Results: The cells abutting on the basement membrane acquire GFAP positivity and extend processes. New layers
of tumor cells show a transition between L2 to L3 followed by NFP and Syn positivity in L4&L5. The level of GFAP
+vity in L1&L2 directly proportionate to the percentage of NFP/Syn+vity in L4&L5, on comparing pigmented PMZ
with poorly pigmented PMZ. Tumor cells in the perimantle zone show high NFP [65%] and Syn [35.4%] positivity
with very low GFAP [6.9%] correlating with the positivity in the outer layers.
Discussion: From this study it is seen that melanoma cells revert to the embryonic pattern of differentiation, with
radial glial like cells [GFAP+ve] which further differentiate into neuronal positive cells [NFP&Syn+ve] during
angiogenic tumor-vascular interaction, as seen during neurogenesis, to populate the tumor substance.
Background
Mammalian melanocytes originate as multipotent neural
crest cells that detach from the neural tube to arrive at
the dorsolateral surface by day 8 [1,2]. Melanomas are
highly malignant tumors arising from the melanocytes,
which are present primarily in the basal layer of the epi-
dermis, but are found in various other locations such as
uveal tract of the eyes, inner ear, mucous membrane,
genital organs, anus and leptomeninges [3]. Cutaneous
melanoma is a tumor derived from activated or geneti-
cally altered epidermal melanocytes, the result of com-
plex interactions between genetic, constitutional, and
environmental factors [4]. Malignant melanoma may
arise from melanocytes in normal appearing skin, acti-
vated melanocytes of solar lentigo, or less frequently
from atypical or relatively benign nevomelanocytic
lesions. The incidence and mortality of cutaneous malig-
nant melanoma has substantially increased among all
Caucasian populations in the last few decades. Suscept-
ibility to melanomas are influenced by various factors
such as familial incidence, race, background, skin types
and gender; constitutional factors such as age, number,
size and type of pigmented nevi; accumulative and life-
time exposure to solar light [5].
The ability of melanoma cells to undergo proliferation
in three dimensions is clinically known as the vertical
growth phase (VGP). VGP melanoma is a highly angio-
genic and proliferative lesion. Further genetic changes
convert melanoma into an invasive tumor capable of
three dimensional growth, increased angiogenesis, and
metastasis [6,7]. The purpose of this study is to assess the
pattern of neural differentiation within the tumor sub-
stance of a series of melanomas in vertical growth phase
[VGP], using the tumor as a three dimensional system.
Materials and methods
A random sample of 27 nodular melanomas in the vertical
growth phase [VGP], were received from the Cancer
Surgery Unit fixed in 10% formol glutaraldehyde. * Correspondence: bhanu_i@yahoo.com
Histochemistry Department, Institute of Pathology, New Delhi - 110037, India
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both in frozen, paraffin sections as well as electron micro-
scopy. 10 nodules were taken from each tumor in the in
the ratio of pigmented to poorly pigmented areas in the
entire tumor. As the specimen were received and sampled
the blocks were arranged in a grid, according to the pig-
ment level which varied between 7% to 95% [Figure 1].
Serial sections 5 μm thick (20-40) frozen sections and
paraffin sections were cut from each block and main-
tained under refrigeration at 4°C. These were subjected
to routine histochemistry, [HE, PAS, reticulin] [8]
enzyme histochemistry [Dopa Oxidase] and immunohis-
tochemistry using the Avidin/Biotin system [HMB45,
NFP, GFAP, Synaptophysin (Syn)], [BioGenex] [9-11].
As negative control all slides included a serial section
stained with no mAb. The same mAb were used simul-
taneously against known positive sections from human
skin as positive controls.
Presence of pigment; a positive DOPA reaction; and
HMB-45 positivity are criteria for diagnosis. In the
a b s e n c eo fp i g m e n tap o s i t i v ed o p ar e a c t i o n ,H M B 4 5
positivity and the presence of premelanosomes on elec-
tron microscopy is diagnostic of poorly pigmented mela-
nomas. These criteria form the basis of diagnosing each
tumor included in this study.
Immunohistochemistry
Neural marker positivity has been examined and com-
pared in:
[a] the general tumor;
[b] perimantle zone [PMZ] of tumor-vascular
complexes [TVC] formed during angiogenesis;
[c] perimantle cells [PC]
Marginal zone between the tumor and stroma were
selected to study the tumor/vascular interaction during
angiogenesis. 51 blocks are from pigmented and 52
from poorly pigmented nodules [Figure 1].
Vascular counts: [Figure 2]
Vascular channels are counted at the tumor margins in
each of the 103 blocks to a depth of two high power fields
Figure 1 Figure showing the pigmented vs poorly pigmented
nodules arranged in a grid in order of the level of
pigmentation in the tumors studied. Nodules marked ‘a’ have
been sectioned to study angiogenesis and tumor vascular
interaction at the tumor stroma interphase.
Figure 2 A scatter diagram comparing the number of vessels
at the margin and within the tumor. The number of angiogenic
vessels is significantly higher at the margin adjacent to the stroma.
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HPF [1030 HPF marginal and 1030 HPF within tumor].
Tumor/vascular Complex [TVC]: [Figure 3 &4]
Perivascular mantle zone [PMZ] The interacting
t u m o rc e l l sf o r mam a n t l ea r o u n dt h ea n g i o g e n i cc h a n -
nels at the stroma/tumor interphase forming spheroidal
structures. 10 random angiogenic vessels with a mantle
of 5 to 6 layers of tumor cells were assessed in each
serial section for the marker positivity. A total of 1030
TVC were assessed which includes 510 [A] pigmented
and 520 [B] with scanty pigment. For analyses the layers
around the vessel are numbered from L1 to L5 with L1
being closest to the vessel. The percentage positivity for
GFAP, NFP, and Syn of each layer is represented as
graphs [Figure 4], to show the marker localization in
relation to the angiogenic central vessel. Specific mor-
phological features in the different layers have been stu-
died to correlate with the immunopositivity.
Perimantle cells
The percentage immunopositive cells around the mantle
zone were counted to a depth of one HPF.
Statistical Analysis
Anova Analysis: Kruskal-Wallis One Way Analysis of
Variance; and Tukey Test: All Pairwise Multiple Com-
parison Procedures.
Results
Pattern of Neural differentiation
The expression of neural markers [GFAP, NFP and Syn],
by melanocytes in association with pigmentation and the
tumor morphology has been examined in this section. It
is observed that the general tumor areas differ from
areas of angiogenesis where there is a patterned neural
expression and melanocyte morphology.
General Tumor
There is a marked anisocytosis and anisonucleosis.
Pleomorphism, increased nuclear-cytoplasmic ratio,
hyperchromatin, enlarged nucleoli, abnormal mitoses
and giant cells are seen. Mononucleate and multinucle-
ate giant cells with 10-12 nuclei are also present. There
is no definite pattern of neural differentiation in areas
unrelated to angiogenesis.
Total nodules [270 nodules]: 69% [186 nodules] of the
all areas studied express the three neural markers [GFAP,
NFP, Syn]; 69.2% [187 nodules] of the melanomas were
positive for GFAP. NFP positivity is observed in 73.1%
[197 nodules], 73.1% were positive for Syn [Figure 4].
Pgmented nodules [135 nodules]: Pigmented nodules
showed extensive positivity for the neural markers, posi-
tivity was seen in: total: 89.8% [121 nodules]; GFAP:
88.5% [120 nodules]; NFP: 88.5%[120 nodules]; Syn:
92.3% [125 nodules] [Figure 4].
Poorly pigmented nodules [135 nodules]: 26.7% [36
nodules] were positive for neural markers, GFAP posi-
tivity was seen in 20% [27 nodules]; NFP and Syn 30%
[40 nodules] positivity was seen in the amelanotic areas
[Figure 4].
Pattern of neural differentiation in relation to
Angiogenesis
The pattern of neural differentiation and cell morphol-
ogy is regimented and well defined at the tumor/stroma
interphase where the tumor cells interact with the neo-
vascular angiogenic vessels. This pattern is lost within
the general tumor away from the margins.
Angiogenesis: [Figure 2]
The adjacent stromal blood vessels proliferate, to extend
endothelial buds which grow towards the tumor margin.
These cannelise and acquire a basement membrane at
the tumor margins. The blood vessels branch extensively
within the tumor substance.
Figure 3 Tumor vascular complexes showing [a] GFAP
positivity in the perivascular layers 1&2 [mAbGFAPX400]; [b]
NFP positivity in layers 4 & 5 [mAbNFPX400]; and [c] Syn
positivity in layer 5 [mAbSynX100]. The cells in the perimantle
zone show a high percentage of NFP & Syn +ve cells and a low
percentage of GFAP +ve cells. [d] Syn positive cells in L4&L5
[mAbSynX1000] showing dendritic processes resembling primitive
neurons. Camera Lucida CL diagrams are shown to highlight the
positive cells.
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quantified by counting the blood vessels [bv] at the mar-
gins and well within the tumor growth. On an average
8.18 bv/HPF are observed near the invasive margins and
an average of 1.9 bv/HPF in the tumor. At the margins a
maximum of 19 bv/HPF and a minimum of 5 bv/HPF are
observed. In the areas of main tumor growth a maximum
of 4 bv/HPF and a minimum of 0 bv/HPF are observed
[Figure 2] Thus as there is a significant difference
between angiogenic vessels at the invasive margins and
within the tumor, in a rapidly growing tumor the central
portions recede from the margins and are deprived of
vascularisation. The tumor cells interact with the angio-
genic vessels at the margins to form a mantle of 5 to 6
cell layers giving a lobular or spheroid appearance.
Tumor vascular interaction: [Figure 3a-d]
A single layer of tumor cells surround the endothelial
tubes and grow out into 5 to 6 concentric layers to
form a compact spheroidal structure clearly demarcated
from the surrounding tumor.
Pattern of neural differentiation related to
neovasculature: [Figure 3&4]
The pattern of differentiation in the tumor cell layers
around the angiogenic vessel, is examined for neuronal
markers GFAP, NFP and Syn. Quantitation and compar-
ison has been given below.
Total PMZ
GFAP: Maximum GFAP positivity is in the layers closer
to the blood vessel being 70.6% in each of the L1 and L2
with 727 of 1030 PMZ showing positivity. GFAP positiv-
ity is 61% [628/1030 PMZ] and 11.8% [122/1030 PMZ] in
L3 and L4. GFAP is absent in the outermost layer i.e. L 5.
NFP: NFP positivity is 23.5% [242/1030 PMZ] and
35.3% [364/1030 PMZ] in the L1 and L2 respectively.
Maximum NFP positivity is in the L3 (64.7%) [666/1030
PMZ] followed by L4 (59.2%) [610/1030 PMZ] and L5
(52.9%) [545/1030 PMZ]
Syn: Syn positivity is 44% in both L1 and L2 [453/
1030 PMZ], and 46.4% in L 3 [478/1030 PMZ]. Maxi-
mum positivity is in the L4 and L5 (64.7% &72%) [666
& 742/1030 PMZ].
A. Pigmented PMZ [510]
GFAP: Highest GFAP positivity is in the L1 and L2
(91.5% & 93%) [467 & 474 of 510 PMZ]. In the outer
layers of the spheroid the GFAP positivity is 62% [316/
510] in L3 and 26.6% [136/510 PMZ] in L4. None of the
tumor areas are positive in the L5.
NFP: NFP positivity is low in the inner layers being
25% [128/510 PMZ] in L1 and 39.7% [202/510 PMZ] in
L2. Maximum NFP positivity (98.8%) [504/510 PMZ] is
Figure 4 Graph showing layer positivity [a] Comparison of immunopositivity for GFAP, NFP and Syn in total, pigmented and poorly
pigmented TVC [b] GFAP, NFP & Syn +vity in the PMZ, perimantle cells and the general tumor.
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maximum positivity being in L3 to L5.
Syn: Syn positivity is higher in the outer layers of the
PMZ as compared to the inner layers. The positivity is
50% [255/510 PMZ] in L1, L2 and 67.7% [345/510
PMZ] in L3. In the L4 and L5 the positivity increases
being 98.9% [504/510 PMZ] and 99.1% [505/510 PMZ]
respectively Thus peak positivity is in the L5.
B. Poorly pigmented PMZ [520]
GFAP: GFAP is expressed in the L1 and L2 where it is
54% & 52.7% [281 & 274/520 PMZ]. The positivity is
60% [312/520 PMZ] in L3 and absent beyond that in
the L4 and L5.
NFP: The overall positivity is low as compared to pig-
mented spheroids. NFP positivity is seen in the L1:
22.3% [116/520 PMZ], 32% [166/520 PMZ] in L2 and
37% [192/520 PMZ] in L3, 33.3% [173/520 PMZ] in L4
and 20% [104/520 PMZ] in L5 showing maximum in L3.
Syn: Syn positivity is 40% [208/520 PMZ] in the L1,
L2 33.3% [173/520 PMZ] in L3, 37.4% [195/520 PMZ]
in L4. The positivity is 50% [260/520 PMZ] in L 5.
On Anova Analysis GFAP is significantly higher
than NFP/Syn in L1&2 [(P = 0.030). F: 13.885] and sig-
nificantly lower in L4&5 [(P = 0.004). F: 59.878 in
L4&5]. Tukey test: All Pairwise Multiple Comparison
P r o c e d u r e s :C o m p a r i s o n : PP<0 . 0 5 0 :G Fv s .N F P : 0 . 0 3 1
Yes; Syn vs. GF:0.004 Yes
Perimantle Zone Cells: [Figure 4&5]
The percentage of perimantle cells [PC] vary. GFAP+ve
cells form 6.9% of the PC, while NFP+ve cells form 65%
and Syn+ve form 35.4% of the cells. This correlates with
the immunopositivity seen in the peripheral layers of
the mantle.
Morphology
The cells in the different layers have defined morpholo-
gies unlike the general tumor. The L1&2 with GFAP
positivity show dendritic cells radial glia-like cells which
extend processes outward into the proliferating layers.
In the outer layers L4&5 Syn positive cells extend pro-
cesses inwards to resemble neuronal cells. [Figure 3d]
Occasional neovascular channels remain quiescent
with a single layer of GFAP negative tumor cells outside
a thin silver positive BM. There is no proliferation as
seen with GFAP positive layer. At the tumor margin,
t h en e wv e s s e l sa r es u r r o u n d e db yf i b r o u st i s s u ea n d
evolve into stromal vessels. The surrounding sheets of
tumor cells unrelated to vessels, show scattered GFAP,
NFP and Syn positivity but no dendricity.
Figure 5 Collage of camera lucida diagrams to compare neuronal immunopositivity in the PMZ and the perimantle zone cells [PC].
The percentage of peripheral cells correlates with the level of marker positivity in the peripheral layers of the PMZ.
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Tumor growth and proliferation is not totally chaotic
and uncontrolled as often misconstrued. This study pro-
vides an interesting aspect of the methods within the
madness of malignant growth in melanomas. Melano-
mas provide a mass of cells as one sees in a 3D matrix.
Analysis of the growth patterns would be of benefit for
the study of embryonic growth patterns as well as for
the study of stem cells. The patterns of neuronal differ-
entiation have been detailed in this work including the
localisation of neural markers [GFAP, NFP and Syn] by
tumor cells in relation to pigmentation. There is a dis-
tinct difference between the general tumor matrix and
areas of angiogenesis where there is a patterned neural
expression and melanocyte morphology.
GFAP positivity identifies the radial glial multipotent
astrocytic stem cells [MASC] during embryogenesis as
described in several studies [12-16]. GFAP, a 50 kDa
intracytoplasmic protein, constitutes the major cytoske-
letal protein in astrocytes and is traditionally referred to
as a specific marker for astrocytes of the CNS [13]
GFAP positivity and glial differentiation is related to
pigmentation and is inversely proportional to astrocytic
anaplasia as is well brought out in this study [17].
Melanomas are highly angiogenic and proliferative
lesions in the vertical growth phase [VGP] [18,19].
Angiogenesis is the sprouting of blood vessels from pre-
existing ones where endothelial buds grow out towards
the tumor margins [20-24].
Reciprocal paracrine interactions between astrocytes,
endothelial cells and ependymal cells have been demon-
strated in recent studies. Vascular endothelial growth
factor (VEGF) is released from both astrocytes and neu-
rons eliciting a burst of mitotic angiogenesis, which is
followed by the production of brain-derived neuro-
trophic factor (BDNF) by the stimulated microvascular
cells [25-27]. In foci of concurrent angiogenesis and
neurogenesis, neuronal progenitor cells are spatially
associated with mitotic endothelial cells, [28-31].
From this study it is observed that the melanoma cells
express characteristics of radial glia, on interaction with
the endothelial tubes and further proliferate and differ-
entiate into cells positive for neuronal markers and thus
resemble MASC which give rise to neuronal differentia-
tion in neurospheres in cultures [14,32-52].
At the tumor/stroma interphase the sprouted endothe-
lial tubes cannelise and acquire a reticulin positive base-
ment membrane. Initially, a single layer of tumor cells
surround the vessels on the outer surface of the base-
ment membrane. The cells abutting on the basement
membrane acquire GFAP positivity and extend pro-
cesses. Concentric layers of tumor cells grow out from
this layer, supported by GFAP positive processes which
extend outward through the layers of tumor cells
towards the periphery [Figure 3a]. Where GFAP positiv-
ity is absent there is no further proliferation. As the new
layers of tumor cells grow out there is a zone where all
three markers are co-localized between L2 to L3 fol-
lowed by NFP and Syn positivity in L4&L5.
Neurofilaments are neuron-specific intermediate fila-
ments which can be localized by NFP positivity for neu-
ronal differentiation [12]. They form the dynamic axonal
cytoskeleton together with other axonal components
such as microtubules to maintain and regulate neuronal
cytoskeletal plasticity [reviewed by Kesavapany et al,
2003] [46]. During development neuroepithelial cells in
the neuronal lineage lose nestin and vimentin [47] to
express NF-H when the maturing cells are forming
synapses [48,49]. NFP positivity is seen in differentiated
ganglion cells, neoplasms of neuronal or mixed cell ori-
gin as well as neuroendocrine tumor cells. Ramirez et al
[50] found rabbit choroidal melanocytes, perivascular
and intervascular fibers positive for NFP.
Synaptophysin is a vesicular integral membrane pro-
tein specifically expressed in neural tissues [51]. Synap-
tophysin labels small synaptic like microvesicles (SLMV)
present in neuroendocrine cells such as the pituitary
and adrenal medulla. Synaptophysin and synaptobrevin
are abundant membrane proteins of neuronal small
synaptic vesicles. These vesicles characterized by synap-
tophysin contain considerable amounts of the biogenic
amines [51,52]. Earlier studies have identified the pre-
sence of biogenic amines in melanocytes. These include
catechol amines as well as indole amines [53-58].
The percentage of GFAP+vity in L1&L2 correlates with
the percentage of NFP/Syn+vity in L4&L5. In the poorly
pigmented PMZ the very low GFAP+vity is associated
with a low NFP/Syn +vity. NFP does not increase beyond
L3. This is in contrast to the pigmented PMZ where high
GFAP+vity in L1/L2 is associated with a similar spike in
NFP/Syn+vity in L4/L5 suggesting that the neuronal
positivity results from the GFAP+vity after passing
through a transitional phase. Thus in those areas where
the level of differentiation is low as seen by the absence
of pigment, the differentiation of the tumor cells into
glial cells on interaction with the neovascular channel is
low. This in turn results in low neuronal differentiation.
Immunopositivity in the immediate proximity of the
PMZ in the perimantle zone reflects that of the periph-
eral layers of the mantle there being a very low GFAP
+vity [6.9%], and high Syn [35.4%] and NFP [65%] posi-
tivity. This suggests that most GFAP +ve cells prolifer-
ate into NFP and Syn +ve cells which then populate the
tumor [Figure 5].
The sequence of progression from radial glial to neuro-
nal positive cells in the [PMZ] simulates the differentiat-
ing patterns in invitro neurospheres and early
embryogenesis of the neural tube. The astrocyte-like
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while newly-generated neurons can assume or revert to
an astrocytic phenotype. In differentiating primary float-
ing neurospheres neurons can shift into cells with astro-
cyte characteristics by transitioning through an “asteron”
(neuron/astrocyte hybrid) morphotype which coexpress a
variety of neuron and astrocyte proteins and genes [42].
From this data it is seen that in melanomas which are
known for pleomorphism and highly variant morphology,
there is an organized pattern of differentiation as the
tumor spreads and vascularises. Interaction with the neo-
vascular angiogenic channels functions as during neuro-
genesis. As the single interacting cell layer proliferates into
a layered mantle a wave of step wise differentiation from
tumor cells to glial followed by neuronal cells positive for
NFP and Syn occurs.
These cells then merge with the expanding tumor
cells to populate it with GFAP, NFP and Syn +ve cells
which acquire the haphazard pattern seen in the general
tumor substance. This mode of patterned growth is pro-
minent in the pigmented nodules and is low in the
poorly pigmented nodules and rare in the amelanotic
melanomas. Thus the more differentiated the tumor the
more regimented the growth pattern.
These results show that the melanoma cells have the
potential for differentiating into glial as well as neuronal
cells. The formation of structured PMZ during tumor
cell-vascular interaction recapitulates embryogenic neu-
rogenesis. Melanoma cells could potentially serve as
neuronal stem cells, when grown as cocultures with
angiogenic/endothelial cells, since in the tumor system
the regimentation is confined to the PMZ, beyond
which the neoplastic cells revert to a chaotic growth
pattern. Although dendritic, Syn positive cells, resem-
bling early neurons are seen in the outer layers of the
PMZ [Figure 3d], in vitro studies are required to con-
firm this potential. In addition the metabolic activity of
melanoma derived stem cells have to be carefully
monitored.
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